Covid-19 Drugs - Thailand Medical News

Austrian Study Shows Calcium Channel Inhibitors Including Amlodipine, Nifedipine, Felodipine And The Phytochemical Neferine Can Treat COVID-19 Infections

Source: Calcium Channel Inhibitors-SARS-CoV-2 Jan 20, 2022 8 days ago

Calcium Channel Inhibitors-SARS-CoV-2: A new study by researchers from the Institute of Biophysics, Johannes Kepler University Linz-Austria has found that calcium channel inhibitors including existing drugs such as amlodipine, nifedipine, felodipine, verapamil and the phytochemical neferine from the lotus plants can possibly treat SARS-CoV-2 infections. Strategies for inhibition of cellular ...

BREAKING! Californian Study Shows That SARS-CoV-2 Infections Can Be Controlled By Inhibiting Human Host SIRT5. SIRT5 Inhibitors As Potential COVID-19 Drugs

Source: SIRT5 Inhibitors As Potential COVID-19 Drugs Jan 11, 2022 17 days ago

A new study by researchers from Buck Institute for Research on Aging-California, Gladstone Institute-California, University of California-San Francisco and the QBI COVID-19 Research Group (QCRG)-California has revealed that the SARS-CoV-2 coronavirus can be inhibited and controlled by downregulating human host SIRT5. The study findings showed that SIRT5 is a proviral factor and that SARS-CoV-2 lev...

Study Shows Ramatroban, A Thromboxane A2 & Prostaglandin D2 Receptor Antagonist Can Be Used To Treat COVID Respiratory Distress And Hypoxemia

Source: COVID-19 Drugs - Ramatroban Jan 03, 2022 25 days ago

COVID-19 Drugs: A small clinical study conducted by researchers from the Charak Foundation-California-USA, Regulatory Wisdom-India, the EyeSight Eye Hospital and Retina Centre-India and the University of California Irvine-USA has found that the drug Ramatroban, which is a thromboxane A2 & prostaglandin D2 receptor antagonist can be used to treat COVID respiratory distress and hypoxem...

BREAKING! Latest German Study Reinforces Past Research Showing Iota-Carrageenan Ability To Inhibit Replication Of All SARS-CoV-2 VOCs.

Source: COVID-19 Prophylactics-Therapeutics Dec 14, 2021 2 months ago

COVID-19 Prophylactics-Therapeutics: Scientist from Friedrich-Alexander University Erlangen-Nürnberg-Germany, Ulm University Medical Center-Germany, University Hospital Tübingen-Germany and Marinomed Biotech AG-Austria have in a new study found that the safe and non-toxic natural compound iota-carrageenan has the ability to inhibit replication of all existing SARS-CoV-2 variants of ...

BREAKING! Cornell Study Find That Entry Of Coronaviruses Is A Ca2+-Dependent Process. Calcium Channel Blockers Could Be Potential COVID-19 Drugs

Source: COVID-19 Drugs - Calcium Channel Blockers Dec 12, 2021 2 months ago

COVID-19 Drugs: A new study by researchers from Cornell University -New York has found that that entry of coronaviruses such as SARS-1, MERS and even SARS-CoV-2 is a Ca2+-dependent process. The study findings also propose that existing FDA approved calcium channel blockers could be repurposed as potential COVID-19 drugs. We are making a special appeal to all readers to please help to sustain this...

BREAKING! Scientists Find That The OTC Drug Diphenhydramine When Paired With Lactoferrin Could Be A New Therapeutic For COVID-19

Source: COVID-19 Drugs Dec 09, 2021 2 months ago

COVID-19 Drugs: A new study by scientists from the University of Florida-USA and the University of Saskatchewan has found that the common over-the-counter antihistamine diphenhydramine when paired with the commonly available supplement lactoferrin, a protein found in cow and human milk, the pair had the capability to hinder the SARS-CoV-2 virus during tests in monkey cells and ...

Much Touted Merck’s COVID-19 Drug-Molnupiravir Shown To Be Less Effective In New Analysis. Experts Question Its Efficacy Against The Omicron Variant

SourceL COVID-19 Drugs - Molnupiravir Dec 05, 2021 2 months ago

COVID-19 Drugs: Updated data on molnupiravir shows the drug reduces hospitalization or death by 30%, down from the initially reported 50% efficacy. Last week Merck has provided updated data on its COVID-19 antiviral, molnupiravir, that shows the antiviral to be significantly less effective against the virus than previously thought. https://www.merck.com/news/merck-and-ridgeback-biotherapeutics-p...

BREAKING! Stanford Study Confirms Favipiravir Use In Mild Or Asymptomatic COVID-19 Patients Has No Efficacy. Doctors Should Be Sued For Prescribing It!

Source: COVID-19 Drug Scams-Favipiravir Nov 29, 2021 2 months ago

Since the beginning of the pandemic, certain countries like China and Japan were advocating the use of Favipravir (Avigan) to treat COVID-19 despite lack of evidence to show its efficacy. Surprisingly, although China was advocating its use to other countries by giving and selling stocks of the drug, it was never really endorsed in its own national guidelines for COVID-19 treatment neither was it u...

Study Shows Potential Of Combining Iota-Carrageenan And Xylitol As A Potential Prophylactic Nasal Spray For COVID-19

Source: COVID-19 Prophylactics-Therapeutics Nov 26, 2021 2 months ago

COVID-19 Prophylactics-Therapeutics: Researchers from the University of Tennessee Health Science Center-USA and Instituto de Ciencia y Tecnología-Argentina have in a new study demonstrated that a combination of iota-carrageenan and xylitol inhibit SARS-CoV-2 in Vero cell culture, paving the way for the development of a prophylactic and therapeutic nasal spray for COVID-19. Since the...

University of California And Stanford Study Shows SSRI Antidepressants Like Fluoxetine Or Fluvoxamine Lowers Risk Of COVID-19 Mortality

Source: COVID-19 Drugs Nov 16, 2021 2 months ago

COVID-19 Drugs: University of California-San Francisco and Stanford University researchers have in a new study involving the meta-analysis of health records from 87 health care centers across America found that individuals taking a class of antidepressants called selective serotonin reuptake inhibitors (SSRIs), especially Fluoxetine or Fluvoxamine were significantly less likely to die of COVID-19 ...

Study Reveals That Low Low-Molecular-Weight Heparin Curtails Duration Of SARS-CoV-2 Infection Besides Reducing Disease Severity And Risk Of Mortality

Source: Medical News-COVID-19 Drugs Nov 14, 2021 2 months ago

COVID-19 Drugs: A new study by Austrian researchers from the Medical University of Vienna, Kaiser Franz Josef Hospital, University of Innsbruck and the Johannes Kepler University-Austria has found that not only does the anticoagulant-low molecular weight Heparin reduces the risk of disease severity and mortality about those with COVID019 but it also curtails the duration of the SARS-CoV-2 Infectio...

China’s Medical Researchers Exploring Hydrogen Therapy (Both Gaseous Inhalation And Hydrogen Water) For COVID-19

Source: COVID-19 Treatments - Hydrogen Nov 13, 2021 3 months ago

COVID-19 Treatments: Researchers from Tianjin Medical University General Hospital-China and Weifang Medical University-China are exploring the usage of hydrogen therapy as a possible adjuvant treatment for COVID-19. COVID-19 is an acute respiratory disease caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has no specific and effective treatment to date except ...

COVID-19 Drug Breakthrough! South Korean Study Demonstrates Potential Of Using Hemin To Treat COVID-19 Via Heme Oxygenase-1 Induction

Source: COVID-19 Drugs Nov 09, 2021 3 months ago

COVID-19 Drugs: A new COVID-19 drug breakthrough study led by researchers from the Department of Infectious Diseases, Konkuk University-Gwangjin-gu-South Korea along with help from Chung-Ang University- Gyeonggi-South Korea has demonstrated that the pharmaceutical product called Hemin can be used to treat COVID-19 via heme oxygenase-1 Induction. The antiviral effects of heme oxygenase-1 (HO-1), a...

BREAKING! Australia Now Turning To Oysters As A Cure For COVID-19! Cavortin A Compound Found In Oysters Could Be A Potential SARS-CoV-2 Antiviral!

Source: SARS-CoV-2 Antivirals Nov 08, 2021 3 months ago

SARS-CoV-2 Antivirals: Maybe as a result of an oversupply of Pacific oysters due to a trade spat with China, Australians are desperate to find alternative uses for their oysters or maybe there is some scientific basis after all since a study has been published in the peer reviewed journal: Reviews In Medical Virology, showing the possible benefits of hemoplymph from Pacific oysters (Crassostrea gi...

The TOGETHER Randomized Clinical Trials Shows That Fluvoxamine Reduces Risk Of COVID-19 Disease Severity And Reduces Need For Hospitalization

Source: COVID-19 Drugs Oct 28, 2021 3 months ago

Fluvoxamine-COVID-19: The results from the TOGTHER clinical trial has shown that fluvoxamine reduces the risk of COVID-19 disease severity and reduces the need for hospitalization. The TOGETHER trial is a randomized, adaptive platform trial to investigate the efficacy of repurposed treatments for COVID-19 disease among high-risk adult outpatients. The trial was designed and done in partner...

German Researcher Highlights The Importance Of Autophagy In Fighting SARS-CoV-2 Infections And Identifies Drugs That Could be Repurposed To Treat COVID-19

Source: Autophagy-SARS-CoV-2 Oct 26, 2021 3 months ago

Autophagy-SARS-CoV-2: A review published by a researcher, Dr Theo Rein from the Max Planck Institute of Psychiatry, Munich-Germany in the peer reviewed Journal of Cellular Biochemistry highlights the importance of autophagy in the fight against SARS-CoV-2 infections and also identifies potential drugs that could be repurposed to treat COVID-19. https://onlinelibrary.wiley.com/doi/10.1002/jcb.30166...

Danish, Canadian & Italian Researchers Finds That The Antimicrobial Drug Atovaquone Has Antiviral Potential Against SARS-CoV-2 & Emerging VOCs!

Source: COVID-19 Drugs Oct 25, 2021 3 months ago

COVID-19 Drugs: A new multinational research involving medical scientists from Aarhus University-Denmark, Istituto Pasteur Italia-Cenci Bolognetti Foundation-Italy, University of Ottawa-Canada and Ottawa Hospital Research Institute-Canada has found that the U.S, FDA approved antimicrobial drug Atovaquone has antiviral potential against the SARS-CoV-2 coronavirus and emerging VOCs and could be repu...

Study Shows That Use of Antithrombotics Such As Aspirin And Apixaban Does Not Help Non-Hospitalized COVID-19 Patients With Mild Or Moderate Symptoms

Source: Antithrombotics-COVID-19 Oct 21, 2021 3 months ago

Antithrombotics-COVID-19: A new multi-institutional clinical study has shown that antithrombotic therapy involving drugs like aspirin or apixaban is not warranted in COVID-19 outpatients. The researchers from Brigham and Women’s Hospital-Massachusetts, University of Pittsburgh-Pennsylvania, University of Illinois-Chicago, Intermountain Healthcare-Utah, National Heart, Lung, and Blood Instit...

Penn State Study Shows That Glucose-Regulating Drugs Like GLP-1R Agonists, DPP-4 Inhibitors & Pioglitazone Reduces Risk Of COVID-19 Severity

Source: COVId-19 Drugs Oct 20, 2021 3 months ago

COVID-19 Drugs: A new multinational retrospective cohort study by researchers from Penn State College of Medicine, Pennsylvania-USA shows that glucose-regulating medications used to treat obesity and type-2 diabetes may improve outcomes in COVID-19 patients with type-2 diabetes. It has already been known that individuals with type 2 diabetes mellitus (T2DM) are at increased risk of severe COVID-1...

New American Study Shows That The Antiemetic Drug Zofran Lowers Risk Of Mortality Of Severe COVID-19 Patients On Ventilators

Source: COVID-19 Drugs Oct 15, 2021 4 months ago

COVID-19 Drugs: A new study that analyzes real-world data utilizing artificial intelligence by researchers from AdventHealth Research Institute-Orlando, Oak Ridge National Laboratory-Tennessee and the University of Tennessee has found that the antiemetic drug Zofran (Ondansetron) lowers risk of mortality of severe COVID-19 patients on ventilators and is associated with increased survival of these ...

Hilarious! Study Confirms Monoclonal Antibody Treatments Are Driving Emergence Of Antibody Resistant Variants But Corrupted US Agencies Are Promoting Them!

Source: Monoclonal Antibodies-SARS-CoV-2 Variants Oct 07, 2021 4 months ago

Monoclonal Antibodies-SARS-CoV-2 Variants: If anything, the COVID-19 pandemic has revealed to those intelligent enough to understand anything that the elites in the United States are nothing more than the most filthy, unethical and greedy and corrupted live forms ever to emerge this earth. From day one of the pandemic, certain American elites have been controlling the narratives of the COV...

Molnupiravir - What's Wrong With America? Why Is the American Government And Agencies Funding And Pushing Potentially Toxic Drugs To Treat COVID-19?

Source: COVID-19 Exposé Sep 24, 2021 4 months ago

COVID-19 Exposé : First it was the Trump Administration along with the U.S.NIH or to be specific the NIAID headed by Anthony Fauci that poured millions of dollars in to the development and research of the overpriced drug remdesivir that is not only hepatoxic but also nephrotoxic to treat COVID-19. There are tons of studies that confirm its toxicity issues, these are just a few. http...

Researcher Proposes Using Aprepitant As A Drug To Target Neurokinin-1 Receptors To Prevent COVID-19 Cytokine Storms

Source: COVID-19-Drugs Sep 22, 2021 4 months ago

COVID-19 Drugs: A researcher from the University of Lahore Pakistan has proposed that the drug aprepitant could be used to target the neurokinin-1 receptors to prevent COVID-19 cytokine storms. Aprepitant is a medication used in the management and treatment of chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea and vomiting (PONV). It is in the neurokinin-1 a...

COVID-19 Drugs: University Of Liverpool Phase 1a Clinical Trial Of Using Nitazoxanide To Treat COVID-19 Shows Potential. Phase 1b/2a Initiated

Source: COVID-19 Drugs Sep 16, 2021 4 months ago

COVID-19 Drugs: The phase 1a clinical trial led by researchers from the University of Liverpool-UK using the antiparasitic drug Nitazoxanide has shown potential in terms of treating the COVID-19 disease. The research team also comprised clinicians and scientist from University of Southampton-UK, University of Cambridge-UK, the Liverpool School of Tropical Medicine-UK and the Liverpool University H...

BREAKING! Randomized Clinical Trial Findings Confirms That Early Treatment With Fluvoxamine Reduces Risk Of COVID-19 Severity And Mortality

Source: COVID-19 Drugs-Fluvoxamine Sep 06, 2021 5 months ago

COVID-19 Drugs: Results from the TOGETHER multi-institutional, multi-country randomized platform clinical trials of various repurposed drugs to treat COVID-19 has shown that treatment with fluvoxamine (100mg twice daily for 10 days) among high-risk outpatients with early diagnosed COVID-19, reduced the need for extended emergency room observation or hospitalization. The institutions ...

University Of California Researchers Exploring Using Ethacridine-An Abortion Drug To Inhibit SARS-CoV-2 By Inactivating Viral Particles

Source: COVID-19 Drugs Sep 04, 2021 5 months ago

COVID-19 Drugs: Researchers from the University of California-San Francisco along with support from Stanford University are exploring the use of the abortion drug Ethacridine to inhibit SARS-CoV-2 by inactivating viral particles and to assess its potential as a prophylaxis and also therapeutic agent to treat COVId-19. Their study findings were published in the peer reviewed journal: PLOS Pathogen...

Breakthrough! University Of Alabama Study Finds That The Drug To Treat Blood Cancer-Venetoclax Could Be Repurposed To Reverse Lung Fibrosis Especially In COVID!

Source: Pulmonary Fibrosis Sep 01, 2021 5 months ago

A new breakthrough study by researchers from University of Alabama at Birmingham-USA has found that the drug Venetoclax used to treat adult patients with Chronic Lymphocytic Leukemia (CLL) could be repurposed to reverse lung fibrosis after successful mouse model drug trials. Venetoclax, sold under the brand names Venclexta and Venclyxto, is a medication used to treat adults with chronic lymp...

COVID-19 Drugs: Cheap Heart Drug-Metoprolol Aids In Treating Severe COVID-19 Says Study Published In Journal of the American College of Cardiology

Source: COVID-19 Drugs Sep 01, 2021 5 months ago

Researchers from the Centro Nacional de Investigaciones Cardiovasculares (CNIC)-Spain and the IIS-Fundación Jiménez Díaz University Hospital-Spain have in a new clinical study discovered that metprolol- a cheap drug widely used to treat cardiovascular disease, is beneficial in treating severely ill COVID-19 patients. Metoprolol, sold under the brand name Lopressor, amo...

BREAKING! American and German Study Shows That Heartburn Drug Famotidine With Aspirin Prevents COVID-19 Disease Severity and Mortality

Source: COVID-19 Drugs Aug 21, 2021 5 months ago

COVID-19 Drugs: A detailed meta-analytical study by researchers from the University of Virginia-USA, Humboldt-Universität zu Berlin-Germany, Freie Universität-Germany and Berlin Institute of Health, of previous research findings including clinical trials has revealed that the heartburn drug famotidine used alongside Aspirin has the potential to prevent disease severity a...

BREAKING! Fluvoxamine- An ‘Inexpensive’ Anti-Depressant Emerging As A Leading Drug Candidate To be Repurposed To Treat COVID-19

Source: COVID-19 Drugs-Fluvoxamine Aug 14, 2021 6 months ago

COVID-19 Drugs: Fluvoxamine, an inexpensive anti-depressant drug is now emerging as a potential candidate to be repurposed to treat COVID-19. Speculations are adrift that Canada might be the first country to approve its usage to treat COVID-19 followed by the United States, India, Brazil and South Africa. Fluvoxamine, sold under the brand name Luvox among others, is an antid...

Stop Using Ivermectin As It Does Not Work On The New SARS-CoV-2 Variants!

Source: COVID-19 Drugs Aug 13, 2021 6 months ago

Despite so many small randomized clinical trials and observational studies that showed Ivermectin could be used to treat COVID-19 during the early stages of the COVID-19 pandemic, physicians, researchers and individuals should stop attempting to treat COVID-19 with Ivermectin as the drug as no efficacy against most of the new variants that are currently dominating various countries. Thailand Medi...

Yale Study Reveals That Enzyme Present In SARS-Cov-2 Known As Coronavirus 3′-5′ Exoribonuclease (ExoN) Is Responsible For Antiviral Drug Resistance

Source: COVID-19 Therapeutics Aug 09, 2021 6 months ago

COVID-19 Therapeutics: A new research led by scientists from Yale University along with other experts from University of Minnesota and Iowa State University has found that a crucial enzyme known as the Coronavirus 3′–5′ exoribonuclease (ExoN) promotes antiviral resistance hence making many identified drugs such as remdesivir, ivermectin and even identified antiviral phytochemical...

BREAKING! Salicylanilides In Anti-Worm Drugs Like Niclosamide Inhibits SARS-CoV-2 Replication And Suppresses Inflammation Causing Cytokines

Source: COVID-19 Drugs Aug 07, 2021 6 months ago

COVID-19 Drugs: A new mouse based vivo study by researchers from the Scripps Research Institute-California along with scientist from the University of Texas and Sorrento Therapeutics Inc.-California have found that salicylanilides which are active pharmaceutical ingredients (APIs) found in drugs used to treat tapeworm infestations demonstrated efficacy in terms of inhibiting the SARS-CoV-2 coronav...

COVID-19 Drugs: Fenofibrate-A Cholesterol Lowering Drug Reduces SARS-CoV-2 Infection By Up To 70 Per Cent According to British and Italian Scientists

Source: COVID-19 Drugs Aug 07, 2021 6 months ago

COVID-19 Drugs: Scientists from the University of Birmingham and Keele University in the UK and the San Raffaele Scientific Institute in Italy have demonstrated that the licensed cholesterol lowering drug fenofibrate and its active form (fenofibric acid) can significantly reduce SARS-COV-2 infection in human cells in the laboratory. Importantly, reduction of infection was obtained using conce...

COVID-19 Drugs: New In Vitro Study Shows That The High Blood Pressure Drug Losartan Inhibits SARS-CoV-2 Replication

Source: COVID-19 Drugs Aug 04, 2021 6 months ago

COVID-19 Drugs: A new in vitro study conducted by researchers from University of Georgia-US and Shahid Beheshti University-Iran has found that the common high pressure drug called Losartan is able to inhibit SARS-CoV-2 coronavirus replication. Losartan, sold under the trade name Cozaar among others, is a medication mainly used to treat high blood pressure. Losartan belongs to a gr...

COVID-19 Therapeutics: MicroRNAs From Plants And Even Humans Might be The Holy Grail To Stopping The SARS-CoV-2 Crisis

Source: miRNAs and SARS-CoV-2 Aug 02, 2021 6 months ago

COVID-19 Therapeutics: Researchers from Gujarat University inspired by Thailand Medical News call to focus on Phytochemicals and microRNAs as solutions to containing the SARS-CoV-2 pandemic have in a new study utilizing computational workflow, identified potential cellular miRNA candidates that are potent in providing antiviral defense against SARS-CoV-2 infection. The study team designed a syste...

COVID-19 Drugs: German Study Confirms The Antiviral Effects Of Budesonide Against The SARS-CoV-2 Coronavirus And Even Against Emerging Variants

Source: COVID-19 Drugs-Budesonide Jul 29, 2021 6 months ago

Another study finding has emerged proving the antiviral effects of Budesonide when used either as an inhaler or as a nasal spray. German researchers from the Ruhr-University Bochum and also from the European Virus Bioinformatics Center (EVBC) based in Jena-Germany have in a new study confirmed the viral effects of Budesonide against the wildtype SARS-CoV-2 coronavirus and even against the ...

Chinese Study Finds That Lectins Derived From Indian Lentils Or Dhal Exhibit Antiviral Properties Against The SARS-CoV-2 Coronavirus.

Source: COVID-19 Antivirals Jul 29, 2021 6 months ago

A new study by scientists from the National Institutes for Food and Drug Control (NIFDC)-China has found that lectins derived from lentils (Lens culinaris)- a staple in Indian cuisine often known as dhal, exhibits antiviral properties against the SARS-CoV-2 coronavirus. The study findings were published in the peer reviewed journal: Emerging Microbes and Infection. https://www.tandfonline.com/doi...

BREAKING! British Study Claims An Abnormal Antibody Response Is What Is Causing Blood Clots In Severe COVID-19 Patients

Source: Breaking COVID-19 News Jul 28, 2021 6 months ago

A new study by researchers from the University of Reading, Reading, United Kingdom has found that inflammation and blood clotting seen in very severe cases of COVID-19 may be caused by the antibodies sent to fight the disease activating unnecessary platelet activity in the lungs. According to the study team a subset of patients with COVID-19 typically become critically ill, suffering from severe ...

American Study Shows That Plant Flavonols And Dihydroflavonols Show Potential As Antivirals As They Inhibit Mpro Of SARS-Cov-2 In Vitro

Source: Herbs and Phytochemicals for COVID-19. Jul 24, 2021 6 months ago

As the COVID-19 pandemic fast accelerates into a more catastrophic mode and there are still no effective antivirals to date plus antibody therapies as well as vaccines are beginning to show signs of being defeated by the new emerging variants, there is a dire need for effective therapeutics against the SARS-CoV-2 coronavirus and various study teams around the world are frantically searching for pr...

Various Studies Are Showing That Reactivation Of Dormant Epstein-Barr Virus Could Be What Is Responsible For COVID Severity As Well As Long COVID

Source: Epstein-Barr virus and COVID-19 Jul 22, 2021 6 months ago

A number of studies are emerging that indicate Epstein-Barr virus (EBV) reactivation may play a role both in the development of long COVID symptoms, as well as severe COVID-19 cases. It has been found that Coronavirus disease 2019 (COVID-19) patients sometimes experience long-term symptoms following resolution of acute disease, including fatigue, brain fog, and rashes. One study published ...

BREAKING! Study Finds That N-Acetylneuraminic Acid And Its Analogs Can Be Used To Prevent Adverse Reactions Due To COVID-19 Infection Or Vaccines

Source: COVID-19 Drugs Jul 19, 2021 6 months ago

A new study by biotech researchers from Hangzhou-China involved in a development of new drug formulation has found that N-Acetylneuraminic Acid (NANA) and its analogs such as acetylneuraminic acid methyl ester (NANA-Me) are able prevent and also treat adverse reactions caused by COVID-19 infections and also by COVID-19 vaccines. Edible Bird's Nest- A Good Source Of N-Acetylneuramin...

COVID-19 Drugs: University Of California Study Confirms That Statins Used To Reduce Cholesterol Levels Can Also Decrease COVID-19 Mortality

Source: COVID-19 Drugs-Statins Jul 16, 2021 7 months ago

COVID-19 Drugs: A new study by researchers from the University of California-San Diego School Of medicine-USA has confirmed that patients taking statin medications had a 41 percent lower risk of in-hospital death from COVID-19. According to the study team, statins have anti-inflammatory and immunomodulatory effects that may reduce the severity of the COVID-19 disease, in which organ dysfunction i...

COVID-19 Therapeutics: Japanese Study Shows That Short Chain Fatty Acids (SCFAs) Could Serve To Contain SARS-CoV-2 By Downregulating ACE2

Source: COVID-19 Therapeutics Jul 15, 2021 7 months ago

COVID-19 Therapeutics: A new study by researchers from University of Fukui-Japan shows that Short Chain Fatty Acids (SCFAs) could be used as potential therapeutics to treat COVID-19 and also to act as a prophylaxis. The researchers showed that SCFAs could downregulate ACE2 in epithelial cells. According to the study team inflammatory endotype affects ACE2 expression in the nasal mucosa and influe...

COVID-19 Clinical Care: Canadian Doctors Say That Early Usage Of Anticoagulants Like Heparin In Moderate COVID-19 Patients Reduces Mortality

Source: COVID-19 Clinical Care-Heparin Jul 14, 2021 7 months ago

COVID-19 Clinical Care: A new study undertaken by medical researchers from the St. Michael's Hospital, a treatment site of Unity Health Toronto and the University of Vermont Larner College of Medicine indicates that administering a full dose of a standard blood thinner early to moderately ill hospitalized patients with COVID-19 could halt the thrombo-inflammation process and reduce the risk of...

American Study Confirms That Aspirin Use Is Associated With Decreased Mortality Risk In COVID-19 Patients

Source: COVID-19 Drugs-Aspirin Jul 14, 2021 7 months ago

Aspirin-COVID-19: A detailed systematic review and meta-analysis study by researchers from the Michigan State University, USA has found that aspirin usage is associated with a significant reduction in overall and in-hospital mortality rates. The current COVID-19 pandemic has so far caused more than 4.05 million deaths and far more are expected to die in coming surges. The benefits of aspir...

BREAKING! French Study Shows That Mannose-Specific Lectins From Plants, Fungi, Algae And Cyanobacteria Can Prevent Various Coronavirus Transmissions Including SARS-CoV-2

Source: Coronavirus News Jul 03, 2021 7 months ago

Coronavirus News: A new study by researcher from Université Paul Sabatier-France, Ecole Nationale Vétérinaire d’Alfort-France, Université Grenoble Alpes-France and also involving scientist from Ghent University-Belgium has shown that mannose-specific lectins derived from plants, algae, fungi, and bacteria selectively bind N-glycans present on the surface of ...

COVID-19 Drugs: Usage Of Pyrimidine Biosynthesis Inhibitors Such As Mycophenolate, Azathioprine And Leflunomide In Conjunction With Nucleoside Analogs Inhibits SARS-CoV-2

Source: COVID-19 Drugs Jul 03, 2021 7 months ago

COVID-19 Drugs: A new study by American and Swiss researchers from University of Pennsylvania , University of Maryland, National Institutes of Health-USA and Epithelix-Switzerland demonstrates that usage of pyrimidine biosynthesis inhibitors such as Mycophenolate, Azathioprine And Leflunomide in conjunction with nucleoside analogs (Examples of such nucleoside analogs include Remdesivir and M...

COVID-19 Treatments: Metabolic activators Such As N-Acetyl-L-Cysteine, L-Carnitine Tartrate, Nicotinamide Riboside, L-Serine Can Reduce Recovery Time In COVID-19 Patients

Source: COVID-19 Drugs And Supplements Jul 01, 2021 7 months ago

COVID-19 Treatments: A new study by researchers from the Royal Institute of Technology-Sweden, University of Health Sciences-Turkey, Istanbul Technical University-Turkey, Atatürk University-Turkey, Chalmers University of Technology-Sweden, University of Gothenburg and Sahlgrenska University Hospital-Sweden and Istanbul Medipol University-Turkey has found that metabolic activators such as nico...

COVID-19 Drugs: Study Published In Journal Of The Heart Rhythm Society Warns That Remdesivir Can Cause Dangerously Low Heart Rate In COVID-19 Patients

Source: COVID-19 Drugs Jun 30, 2021 7 months ago

Remdesivir the controversial drug that was deemed to be ineffective in WHO’S SolidarityTrial (https://www.thailandmedical.news/news/latest-who-s-solidarity-drug-trial-shows-that-remdesivir-is-not-the-least-effective-in-treating-covid-19) but is still being approved as a drug to treat COVID-19 under EUA status in the United States by the no longer credible US FDA is now facing more backlash a...

COVID-19 Drugs: Canadian COLCORONA Study Shows That Colchicine Can Reduce Certain Complications Of COVID-19

Source: COVID-19 Drugs May 31, 2021 8 months ago

COVID-19 Drugs: Canadian researchers from the Montreal Heart Institute (MHI) and the Université de Montréal announced the clinical trial findings of the COLCORONA study (NCT04322682), which was a phase 3, randomized, double-blind, adaptive, placebo-controlled, multicentre trial of the oral anti-inflammatory medication called Colchicine on hospitalized COVID-19 patients. The stu...

BREAKING! India Approves 2-Deoxy-D-Glucose (2-DG) As An Adjuvant To Treat COVID-19 Patients And Reduce Supplemental Oxygen Dependence

Source: COVID-19 Drugs May 08, 2021 9 months ago

COVID-19 Drugs: About 3 hours ago, the Indian drug regulatory body, DCGI has granted emergency approval for the drug 2-deoxy-D-glucose (2-DG) developed by Institute of Nuclear Medicine and Allied Sciences, a lab of DRDO, in collaboration with Dr Reddy’s Laboratories, Hyderabad, as an adjuvant drug to treat hospitalized COVID-19 patients and also to reduce supplemental oxygen dependence. &n...

COVID-19 Drugs: Latest Japanese Study Shows Association Between High Serum Favipiravir Concentrations And Drug-Induced Liver Injury!

Source: COVID-19 Drugs May 06, 2021 9 months ago

COVID-19 Drugs: A new research by researchers from Japan shows that the teratogenic drug: Favipiravir that certain ignorant countries are using to treat COVID-19 can also induced liver injury if the serum concentration of the drug exceeds a certain threshold! The study findings were published on a preprint server and are currently being peer reviewed by teams from the United States ...

American Study Shows That Taking Low Dose Aspirin Decreases Risk Of Severity And Mortality When Infected With COVID-19

Source: Aspirin-COVID-19 Mar 21, 2021 10 months ago

A new study led by researchers from George Washington University and also included scientists from the University of Maryland, Wake Forest School of Medicine, Northeast Georgia Health System, Walter Reed National Military Medical Center, University of California-San Francisco and the University of Oklahoma School of Medicine have found that low dose aspirin may reduce the need for mechanical venti...

COVID-19 Antivirals: Japanese Study Shows That Oxidized Cholesterol Derivatives Or Oxysterol Shows Antiviral Activity Against SARS-CoV-2

Source: COVID-19 Antivirals Feb 04, 2021 12 months ago

COVID-19 Antivirals: Japanese researchers from National Institute of Infectious Diseases, Tokyo and the Tokyo University of Science have in a new study found that oxidized cholesterol derivatives or oxysterol exhibits potent antiviral activity against the SARS-Cov-2 coronavirus. Developments of effective antiviral drugs targeting SARS-CoV-2 are urgently needed to combat the COVID-19 disea...

Interesting Reads

COVID-19 News: Emerging Studies Shows SARS-CoV-2 Attacks The Digestive Tract Especially The Intestines Directly, Reported Case Of Bowel Perforation

Source: COVID-19 News
Sep 21, 2020 1 year ago

BREAKING! COVID-19 Symptoms: King’s College London and Massachusetts General Hospital Identify Six Specific Symptom Cluster ‘Types’ Of COVID-19 Infections.

Source: COVID-19 Symptoms
Jul 20, 2020 2 years ago

BREAKING NEWS! COVID-19 Alert: Research Led By Cedars-Sinai Indicates That Proton Pump Inhibitors (PPIs) Use Is Linked To Increased Risk Of COVID-19

Source: COVID-19 Alert
Jul 08, 2020 2 years ago

BREAKING NEWS! Study Of COVID-19 Recovered Patients In China Reveals That Lymphocytes Are Drastically Altered To Become Dysfunctional With Immunity Implications

Source: COVID-19 Recovered Patients
Jul 02, 2020 2 years ago

Occulus Hirsutus and AQCH: India Discreetly Developing And Testing COVID-19 Drug Based On Phytochemicals Extracted From Occulus Hirsutus Plant

Source: Occulus Hirsutus and AQCH
Jun 27, 2020 2 years ago

High-Flow Nasal Cannula: For COVID-19 Second Wave Preparations, Forget About Ventilators, Doctors Are Now Turning To High-Flow Nasal Cannula

Source: High-Flow Nasal Cannula
Jun 25, 2020 2 years ago

BREAKING! Androgens: Study Shows Bald Men Mostly Likely To Suffer Severe COVID-19 Conditions Due To High Levels Of Androgens

Source: Androgens And COVID-19
Jun 23, 2020 2 years ago

BREAKING! Hepatitis B: UAE COVID-19 Case Study Indicates That COVID-19 Could Induce Hepatitis B Virus Reactivation

Source: Hepatitis B and COVID-19
Jun 21, 2020 2 years ago

BREAKING! COVID-19 Research: Sodium Channels Could Be Affected As Coronavirus Spike Protein Has Similar Sequence To Human Epithelial Sodium Channel

Source: COVID-19 Research
Jun 21, 2020 2 years ago

BREAKING! Cannabis And COVID-19: Caflanone, A Flavonoid Extracted From A Distinct Cannabis Strain Could be A Therapeutic Drug Against the COVID-19

Source: Cannabis And COVID-19
Jun 20, 2020 2 years ago

Gargling: New Studies Show That Throat Gargling May Be Beneficial After All During COVID-19 Despite Being Labeled In the Past As Misinformation

Source: Gargling and COVID-19
Jun 19, 2020 2 years ago

BREAKING! COVID-19 Research: New Study Reveals That SARS-CoV-2 Coronavirus Also Affects Thyroid Functions In Majority Of COVID-19 Patients

Source: COVID-19 Research
Jun 17, 2020 2 years ago

Inhaled Corticosteroids Downregulates The SARS-CoV-2 Receptor ACE2 In COPD Through Suppression Of Type I Interferon

Source: Inhaled Corticosteroids And COVID-19
Jun 15, 2020 2 years ago

COVID-19 Convalescent Plasma Therapy Soon To Be Superseded By More Effective Hyperimmune Plasma Or H-Ig Therapies

Source: COVID-19 Convalescent Plasma and Hyperimmune Plasma Or H-Ig Therapies
Jun 15, 2020 2 years ago

Exploring Inhaled Nitric Oxide (iNo) As As An Adjuvant COVID-19 Treatment For Pulmonary Issues

Source: Nitric Oxide and COVID-19
Jun 15, 2020 2 years ago

Understanding The Differences Between COVID-19 Asymptomatic and Presymptomatic Conditions

Source: COVID-19 Asymptomatic and Presymptomatic
Jun 14, 2020 2 years ago

Researchers Say One Potential Long-Term Health Implication Of COVID-19 Could Be Hearing Loss

Source: COVID-19 Long-Term Health Implications
Jun 13, 2020 2 years ago

Scripp Institute Has Detected The Mutation That Most Scientist Dread: The D614G Mutation Which Could Make The SARS-CoV-2 More Infectious

Source: SARS-CoV-2 Mutations
Jun 13, 2020 2 years ago

Niclosamide Shows Efficacy Against COVID-19 In Animal Tests According To South Korean Pharmaceutical Giant Daewoong

Source: Niclosamide & COVID-19
Jun 13, 2020 2 years ago

BREAKING! Medical Experts Warn That COVID-19 Could Trigger Diabetes In Otherwise Healthy Individuals Who Never Had The Condition Before.

Source: Diabetes and COVID-19
Jun 13, 2020 2 years ago

Northwestern University Issues COVID-19 Warning That The Whole Nervous System Can Be Affected By The SARS-CoV-2 Coronavirus

Source: COVID-19 Warning
Jun 12, 2020 2 years ago

Acute Pancreatitis: Warning That Acute Pancreatitis Is Now Manifesting In COVID-19 Patients, A Condition Never Seen In Early Stages Of The Pandemic

Source: Acute Pancreatitis
Jun 11, 2020 2 years ago

Could Pollen Play A Role In Influenza And COVID-19 Seasonality?

Source: COVID-19, Influenza and Next Wave
Jun 10, 2020 2 years ago

COVID-19 Drugs: Ivermectin Reduces Mortality Rates In Hospitalized COVID-19 Patients In A Cohort Clinical Study Conducted In South Florida

Source: COVID-19 Drugs and Ivermectin
Jun 10, 2020 2 years ago

Immune Health: Cistanche And Pu-erh Tea Supplements Could Help Improve Immune Factors And Reduce Pro-inflammatory Cytokines Such As Interleukin-6

Source: Immune Health
Jun 09, 2020 2 years ago

Study Finds That COVID-19 Also Causes Myocardial Injury (Heart Damage)

Source: Myocardial Injury
Jun 09, 2020 2 years ago

European COVID-19 Research Indicates That Individuals With Blood Group Type A Might Be More Vulnerable To Respiratory Failure

Source: COVID-19 Research
Jun 08, 2020 2 years ago

COVID-19 Research: Study From Columbia University Indicates That Lowering Testosterone Levels Could Reduce Severity Of COVID-19

Source: COVID-19 Research
Jun 08, 2020 2 years ago

Uric Acid: Japanese Researchers Discover That High Uric Acid Levels Protects Against Lung Function Decline Especially In Older Women

Source: Uric Acid Supplements
Jun 07, 2020 2 years ago

MUST READ! Strokes: Study Shows COVID-19 Increases Risk Of Strokes In Healthy Young Individuals. Global Increase In Stroke Deaths Last Few Months

Source: Strokes And COVID-19
Jun 05, 2020 2 years ago

BREAKING! Studies Show Famotidine, A Common Indigestion Drug Could Help In Mild To Moderate Cases Of COVID-19

Source: Famotidine And COVID-19
Jun 05, 2020 2 years ago

BREAKING! Pediatrics: Study Indicates That Multisystem Inflammatory Syndrome More Predominant Among Children Of African Ancestry Infected With COVID-19

Source: Pediatrics
Jun 04, 2020 2 years ago

Pregnancy And COVID-19: Study Shows Choline Supplements Could Help Pregnant Women Reduce Negative Effects Of COVID-19 In Newborns

Source: Pregnancy And COVID-19
Jun 02, 2020 2 years ago

COVID-19 Research: University Of Massachusetts Study Warns Of Emerging Genomic Variants In SARS-CoV-2 Coronavirus That Could Lead To Drug Resistance

Source: COVID-19 Research
May 29, 2020 2 years ago

Covid-19: New Study Published In JAMA Says Certain COVID-19 Recovered Patients Still Test Positive Even Days After Being Discharged

Source: Covid-19
May 29, 2020 2 years ago

BREAKING! Coronavirus Latest: Louisiana State University Pathologists’ First COVID-19 Autopsy Series Reveals Cardiopulmonary Anomalies

Source: Coronavirus Latest
May 28, 2020 2 years ago

MUST READ!!! Brazilian Respiratory Expert Says That COVID-19 Should Be Treated As A Thrombotic Disease

Source: COVID-19
May 28, 2020 2 years ago

COVID-19 Research: New Study Reveals That Specific Types Of T-Cells Are Targeted By The SARS-CoV-2 Coronavirus In Patient’s Immune System

Source: COVID-19 Research
May 27, 2020 2 years ago

COVID-19 Research: Could Disulfiram- A Drug To Prevent Alcoholism, Aid In Inhibiting Cytokine Storms In COVID-19?

Source: Covid-19 Research
May 26, 2020 2 years ago

BREAKING ALERT! COVID-19: Italian Researchers Discover Brain Lesions On COVID-19 Patients

Source: COVID-19
May 23, 2020 2 years ago

WARNING! COVID-19 Patients Could Also Develop Thyroid Infections

Source: COVID-19 News
May 21, 2020 2 years ago

COVID-19: Study Shows That COVID-19 Infections Could Lead To Delirium, PTSD and Other Psychiatric Disorders

Source: COVID-19 News
May 19, 2020 2 years ago

COVID-19 Supplements: Silymarin From Milk Thistle Could Perhaps Also Be Used As An Adjuvant Supplement To Help COVID-19 Patients

Source: COVID-19 Supplements
May 18, 2020 2 years ago

MUST READ! COVID-19 Supplements: Could Rutin Be The Secret Ingredient In China’s TCM Formulations That Helped Treat COVID-19 As Adjuvant Protocols?

Source: COVID-19 Supplements
May 15, 2020 2 years ago

BREAKING! COVID-Research: Study Confirms That SARS-CoV-2 Coronavirus Can Be Spread Through Speech

Source: COVID-19 Research
May 14, 2020 2 years ago

COVID-19 Research: Worrying Gastrointestinal Abnormalities Revealed In Abdominal Imaging Studies Of COVID-19 Patients

Source: COVID-19 Research
May 12, 2020 2 years ago

COVID-19 Clinical Care: Kidney Failure Emerging As A Common Occurrence From COVID-19 Infections

Source: COVID-19 Clinical Care
May 12, 2020 2 years ago

MUST READ! COVID-19 Alerts: Children Are At High Risk For Critical Complications And Death From COVID-19

Source: COVID-19 Alerts
May 12, 2020 2 years ago

COVID-19 Therapeutics: Computational Screenings Show A Variety Of Natural Phytochemicals Could Have Efficacy Against SARS-CoV-2 Including EGCG From Green Tea

Source: COVID-10 Therapeutics
May 11, 2020 2 years ago

COVID-19 Drugs: Study Shows Common And Cheap Heartburn Drug Famotidine Improves Outcomes Of Hospitalized COVID-19 Patients

Source: COVID-19 Drugs
May 11, 2020 2 years ago

COVID-19 Warnings! SARS-CoV-2 Coronavirus Infection Could Activate Dormant Tuberculosis

Source: COVID-19 Warnings
May 09, 2020 2 years ago

COVID-19 Supplements: New Study Shows Vitamin D Could Be Linked To COVID-19 Mortality And Infection Rates

Source: COVID-19 Supplements
May 08, 2020 2 years ago

Breaking News! COVID-19 Alerts: British Doctors Warns Of New Anomaly Of COVID-19 Patients Appearing Normal Despite Suffering From Severe Hypoxia

Source: COVID-19 Alerts
May 04, 2020 2 years ago

BREAKING! COVID-19 Research: Glycosaminoglycans Such As Heparin Could Emerge As New Antivirals For COVID-19 Disease

Source: COVID-19 Research
May 04, 2020 2 years ago

COVID-19 Research: Study Shows How Cytokine Storms Actually Depletes T-Cells In COVID-19 Patients

Source: COVID-19 Research
May 03, 2020 2 years ago

COVID-19 Supplements: Study Shows Dietary Selenium Influences Outcome Of COVID-19 Disease

Source: COVID-19 Supplements
Apr 30, 2020 2 years ago

MUST READ! Research Reveals That COVID-19 Attacks Hemoglobin In Red Blood Cells, Rendering It Incapable Of Transporting Oxygen. Current Medical Protocols Could All Be Wrong!

Source: COVID-19 Research
Apr 09, 2020 2 years ago

Covid-19 Clinical Care: Acute Gastrointestinal Injury Occurs In Almost 86 Percent Of Critical Condition Covid-19 Patients, Often Leading To Sepsis And Death

Source: Covid-19 Clinical Care
Mar 30, 2020 2 years ago

Covid-19 Clinical Care: Guidelines To Prevent Drug-Induced Prolongation Of QTc That Often Results In Sudden Cardiac Death In Covid-19 Patients

Source: Covid-19 Clinical Care
Mar 26, 2020 2 years ago

Covid-19 Clinical Care: Doctors Warned About Using ECMO On Covid-19 Patients Due To Lymphopenia

Source: Covid-19 Clinical Care
Mar 25, 2020 2 years ago

Covid-19 Clinical Care: New Medical Study Shows That COVID-19 Patients In Severe Conditions Should Lie Face Down To Facilitate Breathing

Source: Covid-19 Clinical Care
Mar 25, 2020 2 years ago

Breaking! Medical Experts Say That Anosmia Which Is The Loss Of Smell And Ageusia Which Is Loss Of Taste, Could Be Signs Of Covid-19 Infection.

Source: Covid-19 News
Mar 23, 2020 2 years ago

BREAKING NEWS! Study Confirms That Lopinavir–Ritonavir Ineffective In Treating Covid-19

Source: Covid-19 Treatments And Drugs News
Mar 20, 2020 2 years ago

WARNING! Medical Experts Are Saying That The SARS-CoV-2 Coronavirus Could Attack In A Series Of Waves With New Mutated Strains

Source: SARS-Cov-2 Research
Mar 17, 2020 2 years ago

BREAKING! Coronavirus Research Reveals That People With Blood Type A Have Higher Risk Of Contracting Covid-19 Compared To Blood Type O Which Has A Lower Risk

Source: Coronavirus Research
Mar 17, 2020 2 years ago

BREAKING! New Coronavirus Research Shows That The SARS-CoV-2 Coronavirus Has A Fourth Route Of Attacking Human Host Cells Making It A Real Super Virus

Source: Coronavirus Research
Mar 15, 2020 2 years ago

Breaking News! New Covid-19 Research Shows That Viral Shedding Duration By Infected SARS-CoV-2 Coronavirus Patients Can Between 8 to 37 Days

Source : Covid-19 Research News
Mar 12, 2020 2 years ago

BREAKING! More Emerging Chinese Research Studies Shows That The SARS-Cov-2 Coronavirus Also Attacks The Kidneys, Pancreas and Liver

Source: Coronavirus Research
Mar 11, 2020 2 years ago

Breaking News! SARS-CoV-2 Coronavirus Also Detectable In Urine Samples

Source: SARS-Cov-2 Coronavirus Research
Mar 08, 2020 2 years ago

Coronavirus Might Be Affecting The World For The Next 18 Months Or More While WHO Says The Virus Will Most Likely Not Retreat For Summer

Source: Covid-19 News
Mar 07, 2020 2 years ago

Breaking! New Studies Shows How Coronavirus Affects GI Tract and Also Highlights Fecal Transmissions As Another Route For Viral Spread

Source: Coronavirus Research
Mar 06, 2020 2 years ago

BREAKING NEWS: Recovered Patient In Japan Gets Reinfected. New York Microbiologists Warns That Coronavirus Remains Dormant In Treated Patients But For A While

Source: Coronavirus Reinfections News
Feb 27, 2020 2 years ago

Breaking! The Evolving Coronavirus Is Outwitting The World! Quarantines Deemed As Non-Effective As Incubation Period Can Be Limitless! Diagnostics Also Being Questioned

Source : Coronavirus News
Feb 26, 2020 2 years ago

WARNING! As Coronavirus Spreads Worldwide, It Is Evolving And New Anomalies Being Reported. British Epidemiologist Are Predicting That Coronavirus Could Be Affecting The World For Another 18 Months If Not Longer.

Source : Thailand Medical News
Feb 25, 2020 2 years ago

MUST READ! New Research Indicates That Certain Nutraceuticals Could Help In Both Influenza And Coronavirus Infections

Source: Thailand Medical News
Feb 25, 2020 2 years ago

What Constitutes A Fever When We Are Talking About The Coronavirus.

Source : Thailand Medical News
Feb 11, 2020 2 years ago

FROM MEDICAL SUPPORT GROUPS

Health Support Groups in Thailand (And How They Aid Recovery)

LATEST ON DIETS AND NUTRITION

World COVID-19 News

COVID-19 Diagnostics

COVID-19 Drugs

COVID-19 Supplements

COVID-19 Herbs

COVID-19 Disinfectants

COVID-19 Mutations

COVID-19 Research

COVID News

Long COVID

COVID-19 Vaccines

COVID-19 Clinical Care

Medical Press Releases

Medical Innovations & Startups

AI in Medicine

Thailand Biotech News

Medical Spheres Bulletins

Medical White Papers

Medical Packages

Medical Tips

Medical Support Groups

MOST READ

Interesting Reads

FROM MEDICAL SUPPORT GROUPS

LATEST ON DIETS AND NUTRITION